Risk of vertical HIV transmission combines the 'B35-Cw4 disadvantage' and the 'pattern of inheritance' theories of progression

Current HIV Research

Volumn 7, Issue 3, 2009, Pages 314-319

  Arnaiz Villena, Antonio ^a   Martín Villa, José Manuel ^a   Amador, José Tomás Ramos ^b   Cendoya Matamoros, Almudena ^c   Tomé, Maria Isabel González ^c   Rivera, José María ^a   Martinez Quiles, Narcisa ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

HIV vertical infection; HLA disadvantage; Major Histocompatibility complex; Pattern of inheritance; Progression to AIDS

Indexed keywords

HLA A1 ANTIGEN; HLA A11 ANTIGEN; HLA ANTIGEN; HLA B35 ANTIGEN; HLA CW4 ANTIGEN; HLA DR4 ANTIGEN; UNCLASSIFIED DRUG; HLA C ANTIGEN; HLA-CW4;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALLELE; CHILD; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; HAPLOTYPE; HLA SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION SENSITIVITY; INHERITANCE; MAJOR CLINICAL STUDY; REVIEW; RISK FACTOR; SPAIN; VERTICAL TRANSMISSION; VIRUS TRANSMISSION; ARTICLE; COHORT ANALYSIS; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; GENETICS; NEWBORN;

ADULT; COHORT STUDIES; DISEASE SUSCEPTIBILITY; FEMALE; GENE FREQUENCY; HIV INFECTIONS; HLA-B35 ANTIGEN; HLA-C ANTIGENS; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; RISK FACTORS; SPAIN; YOUNG ADULT;

EID: 67649094218     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016209788348029     Document Type: Review

References (27)

1. Hill AV. The immunogenetics of human infectious diseases. Ann Rev Immunol 1998; 16: 593-617.
2. Fauci AS. Host factors and the pathogenesis of HIV-induced disease. Nature 1996; 384: 529-34.
3. Buchacz KA, Wilkinson DA, Krowka JF, Koup RA, Padian NS. Genetic and immunological host factors associated with susceptibility to HIV-1 infection. AIDS 1998; 12(Suppl A): S87-94.
4. Zimmerman PA, Buckler-White A, Alkhatib G, et al. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk. Mol Med 1997; 3: 23-36.
5. Carrington M, O'Brien SJ. The influence of HLA genotype on AIDS. Ann Rev Med 2003; 54: 535-51.
6. Matt C, Roger M. Genetic determinants of pediatric HIV-1 infection: vertical transmission and disease progression among children. Mol Med 2001; 7: 583-9.
7. MacDonald KS, Matukas L, Embree JE, et al. Human leucocyte antigen supertypes and immune susceptibility to HIV-1, implications for vaccine design. Immunol Lett 2001; 79: 151-7.
8. Farquhar C, Rowland-Jones S, Mbori-Ngacha D, et al. Human leukocyte antigen (HLA) B*18 and protection against mother-to-child HIV type 1 transmission. AIDS Res Hwn Retrov 2004; 20: 692-7.
9. Winchester R, Chen Y, Rose S, Selby J, Borkowsky W. Major histocompatibility complex class II DR alleles DRB1*1501 and those encoding HLA-DR13 are preferentially associated with a diminution in maternally transmitted human immunodeficiency virus 1 infection in different ethnic groups: determination by an automated sequence-based typing method. PNAS 1995; 92: 12374-8.
10. Winchester R, Pitt J, Charurat M, et al. Mother-to-child transmission of HIV-1: strong association with certain maternal HLA-B alleles independent of viral load implicates innate immune mechanisms. JAIDS 2004; 36: 659-70.
11. MacDonald KS, Embree J, Njenga S, et al. Mother-child class I HLA concordance increases perinatal human immunodeficiency virus type 1 transmission. J Infect Dis 1998; 177: 551-6.
12. Matte C, Zijenah LS, Lacaille J, Ward B, Roger M. Mother-to-child human leukocyte antigen G concordance: no impact on the risk of vertical transmission of HIV-1. AIDS 2002; 16: 2491-4.
13. Aikhionbare FO, Hodge T, Kuhn L, Bulterys M, Abrams EJ, Bond VC. Mother-to-child discordance in HLA-G exon 2 is associated with a reduced risk of perinatal HIV-1 transmission. AIDS 2001; 15: 2196-8.
14. Kuhn L. Abrams EJ, Palumbo P, et al. Perinatal AIDS Collaborative Transmission Study Group. Maternal versus paternal inheritance of HLA class I alleles among HIV-infected children: consequences for clinical disease progression. AIDS 2004; 18: 1281-9.
15. Martinez-Laso J, Martin-Villa JM, Alvarez M, Martinez-Quiles N, Lledo G, Arnaiz-Villena A. Susceptibility to insulin-dependent diabetes mellitus and short cytoplasmic ATP-binding domain TAP2*01 alleles. Tissue Antigens 1994; 44: 184-8.
16. Mittal KK, Mickey MR, Singal DP, Terasaki PI: Serotyping for homotransplantation. Refinement of microdroplet lymphocyte cytotoxicity test. Transplantation 1968; 6: 913-27.
17. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39: 225-35.
18. Svejgaard A, Platz P, Ryder LP. HLA and disease 1982 - a survey. Immunol Rev 1983; 70: 193-218.
19. Carrington M, Nelson OW, Martin MP, et al. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 1999; 283: 1748-52.
20. Scorza Smeraldi R, Fabio G, Lazzarin A, Eisera NB, Moroni M, Zanussi C. HLA-associated susceptibility to acquired immunodeficiency syndrome in Italian patients with human-immunodeficiency-virus infection. Lancet 1986; 2: 1187-9.
21. Shankarkumar U. HIV and human leukocyte antigen association - the Indian scenario. J HIV Ther 2004; 9: 60-4.
22. Kawana A, Tomiyama H, Takiguchi M, Shioda T, Nakamura T, Iwamoto A. Accumulation of specific amino acid substitutions in HLA-B35-restricted human immunodeficiency virus type 1 cytotoxic T lymphocyte epitopes. AIDS Res Hum Retrov 1999; 15: 1099-107.
23. Roe DL, Lewis RE, Cruse JM. Association of HLA-DQ and -DR alleles with protection from or infection with HIV-1. Exp Mol Pathol 2000; 68: 21-8.
24. Fleury S, Thibodeau J, Croteau G, et al. HLA-DR polymorphism affects the interaction with CD4. J Exp Med 1995; 182: 733-41.
25. Henderson LE, Sowder R, Copeland TD, et al. Direct identification of class II histocompatibility DR proteins in preparations of human T-cell lymphotropic virus type III. J Virol 1987; 61: 629-32.
26. Pillay T, Phillips RE. Adaptive evolution in perinatal HIV-1. Best Pract Res: Clin Obstet Gyn 2005; 19: 211-29.
27. Goulder PJ, Brander C, Tang Y. Evolution and transmission of stable CTL escape mutations in HIV infection. Nature 2001; 412: 334-8.